Skip to main content

Articles

Page 44 of 76

  1. MEIS2 has been identified as one of the key transcription factors in the gene regulatory network in the development and pathogenesis of human cancers. Our study aims to identify the regulatory mechanisms of ME...

    Authors: Lei Guan, Ting Li, Nanping Ai, Wei Wang, Bing He, Yanxia Bai, Zhaocai Yu, Mingyue Li, Shanshan Dong, Qingge Zhu, Xiao Xiao Ding, Shiming Zhang, Ming li, Guangbo Tang, Xiaochun Xia, Jing Zhao…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:417
    Content type: Research Published on:

  2. An increasing number of studies have shown that long noncoding RNAs (lncRNAs) play essential roles in tumor initiation and progression. LncRNAs act as tumor promoters or suppressors by targeting specific genes...

    Authors: Kun Qiao, Shipeng Ning, Lin Wan, Hao Wu, Qin Wang, Xingda Zhang, Shouping Xu and Da Pang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:418
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:154

  3. Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoc...

    Authors: Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre and Michele Maio
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:419
    Content type: Review Published on:

  4. Glioblastoma is the most common and aggressive brain tumour in adults with a median overall survival of only 14 months after standard therapy with radiation therapy (IR) and temozolomide (TMZ). In a novel mult...

    Authors: Ina Patties, Sonja Kallendrusch, Lisa Böhme, Eva Kendzia, Henry Oppermann, Frank Gaunitz, Rolf-Dieter Kortmann and Annegret Glasow
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:420
    Content type: Research Published on:

  5. The monocyte chemoattractant protein-induced protein (MCPIP) family consists of 4 members (MCPIP1–4) encoded by the ZC3h12A-D genes, which are located at different loci. The common features of MCPIP proteins are ...

    Authors: Katarzyna Miekus, Jerzy Kotlinowski, Agata Lichawska-Cieslar, Janusz Rys and Jolanta Jura
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:421
    Content type: Review Published on:

  6. Cancer-initiating cell (CIC), a functionally homogeneous stem-like cell population, is resonsible for driving the tumor maintenance and metastasis, and is a source of chemotherapy and radiation-therapy resista...

    Authors: Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lianfang Yang, Jiuqing Xie, Xiaotao Li, Wenwei Qiu, Zhengfang Yi and Mingyao Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:422
    Content type: Research Published on:

  7. Galectins are beta-galactose specific binding proteins. In human cancers, including hepatocellular carcinoma (HCC), galectin-1 (Gal-1) is often found to be overexpressed. In order to combat the dismal diagnosi...

    Authors: Zoe Leung, Frankie Chi Fat Ko, Sze Keong Tey, Ernest Man Lok Kwong, Xiaowen Mao, Bonnie Hei Man Liu, Angel Po Yee Ma, Yi Man Eva Fung, Chi-Ming Che, Danny Ka Ho Wong, Ching Lung Lai, Irene Oi-Lin Ng and Judy Wai Ping Yam
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:423
    Content type: Research Published on:

  8. Merkel cell carcinomas (MCCs) are rare, aggressive, therapeutically-challenging skin tumours that are increasing in incidence and have poor survival rates. The majority are caused by genomic Merkel cell polyom...

    Authors: Lucia Cappabianca, Stefano Guadagni, Rita Maccarone, Michela Sebastiano, Alessandro Chiominto, Antonietta Rosella Farina and Andrew Reay Mackay
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:424
    Content type: Research Published on:

  9. In the original publication of this article, [1] the affiliation for Katia Scotlandi needs to be revised, because the author prefers using its Italian name: Experimental Oncology Lab, Experimental Oncology Lab...

    Authors: Claudia Chiodoni, Maria Teresa Di Martino, Francesca Zazzeroni, Michele Caraglia, Massimo Donadelli, Stefania Meschini, Carlo Leonetti and Katia Scotlandi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:425
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:128

  10. Polo-like kinase 3 (PLK3) has been documented as a tumor suppressor in several types of malignancies. However, the role of PLK3 in colorectal cancer (CRC) progression and glucose metabolism remains to be known.

    Authors: Baochi Ou, Hongze Sun, Jingkun Zhao, Zhuoqing Xu, Yuan Liu, Hao Feng and Zhihai Peng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:426
    Content type: Research Published on:

  11. A promising strategy to overcome the chemoresistance is the tumor blood vessel normalization, which restores the physiological perfusion and oxygenation of tumor vasculature. Thalidomide (Thal) has been shown ...

    Authors: Yanwei Shen, Shuting Li, Xin Wang, Mengying Wang, Qi Tian, Jiao Yang, Jichang Wang, Biyuan Wang, Peijun Liu and Jin Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:427
    Content type: Research Published on:

  12. BMP3 gene is often found hypermethylated and hence inactivated in several types of cancers including colorectal cancer (CRC), indicating that it has a suppressor role in carcinogenesis. Though BMP3 is a reliab...

    Authors: Jialing Wen, Xianglin Liu, Yan Qi, Feng Niu, Zhitong Niu, Wenjing Geng, Zhaowei Zou, Renli Huang, Jianping Wang and Hongzhi Zou
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:428
    Content type: Research Published on:

  13. miR-133a-3p has been recently discovered to be down-regulated in various human malignancies, including breast cancer, and reduced miR-133a-3p levels have been significantly associated with breast cancer cell g...

    Authors: Wanyue Shi, Tingting Tang, Xinping Li, Siwei Deng, Ruiyi Li, Yingshan Wang, Yifei Wang, Tiansong Xia, Yanfeng Zhang, Ke Zen, Liang Jin and Yi Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:429
    Content type: Research Published on:

  15. Pancreatic cancer is one of the most lethal malignancies due to frequent late diagnosis, aggressive tumor growth and metastasis formation. Continuously raising incidence rates of pancreatic cancer and a lack o...

    Authors: Claudia M. Kowolik, Min Lin, Jun Xie, Larry E. Overman and David A. Horne
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:431
    Content type: Research Published on:

  16. Inefficient T-cell access to the tumor microenvironment (TME) is among the causes of tumor immune-resistance. Previous evidence demonstrated that targeting CXCR4 improves anti-PD-1/PD-L1 efficacy reshaping TME...

    Authors: Crescenzo D’Alterio, Maria Buoncervello, Caterina Ieranò, Maria Napolitano, Luigi Portella, Giuseppina Rea, Antonio Barbieri, Antonio Luciano, Giosuè Scognamiglio, Fabiana Tatangelo, Anna Maria Anniciello, Mario Monaco, Ernesta Cavalcanti, Piera Maiolino, Giulia Romagnoli, Claudio Arra…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:432
    Content type: Research Published on:

  17. Bladder cancer (BC) is a common urothelial malignancy, characterized by a high recurrence rate. The biology of bladder cancer is complex and needs to be deciphered. The latest evidence reveals the critical rol...

    Authors: Cornelia Braicu, Rares Buiga, Roxana Cojocneanu, Mihail Buse, Lajos Raduly, Laura Ancuta Pop, Sergiu Chira, Liviuta Budisan, Ancuta Jurj, Cristina Ciocan, Lorand Magdo, Alexandru Irimie, Florentin Dobrota, Bogdan Petrut and Ioana Berindan-Neagoe
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:433
    Content type: Research Published on:

  18. Breast cancer (BC) is the most frequent malignant tumor in females and the 2nd most common cause of brain metastasis (BM), that are associated with a fatal prognosis. The increasing incidence from 10% up to 40...

    Authors: Simon Bernatz, Elena I. Ilina, Kavi Devraj, Patrick N. Harter, Klaus Mueller, Sascha Kleber, Yannick Braun, Cornelia Penski, Christoph Renner, Rashi Halder, Lukas Jennewein, Christine Solbach, Frits Thorsen, Bernhard C. Pestalozzi, Axel Mischo and Michel Mittelbronn
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:434
    Content type: Research Published on:

  19. Our previous work demonstrated that lncRNA-MALAT1 was overexpressed in recurrent colorectal cancer (CRC) and metastatic sites in post-surgical patients. However, the upstream regulatory mechanism of MALAT1 is ...

    Authors: Xinnan Wu, Ruixiao Li, Qing Song, Chengcheng Zhang, Ru Jia, Zhifen Han, Lihong Zhou, Hua Sui, Xuan Liu, Huirong Zhu, Liu Yang, Yan Wang, Qing Ji and Qi Li
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:435
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2022 41:205

  20. All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that reprogramming of cellular lipid metabolism contributes to malignant transformati...

    Authors: Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani and Enrico Garattini
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:436
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:496

  22. Glutathione S-transferase zeta 1 (GSTZ1) is the penultimate enzyme in phenylalanine/tyrosine catabolism. GSTZ1 is dysregulated in cancers; however, its role in tumorigenesis and progression of hepatocellular c...

    Authors: Jingjing Li, Qiujie Wang, Yi Yang, Chong Lei, Fan Yang, Li Liang, Chang Chen, Jie Xia, Kai Wang and Ni Tang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:438
    Content type: Research Published on:

  23. ERp57 dysfunction has been shown to contribute to tumorigenesis in multiple malignances. However, the role of ERp57 in clear cell renal carcinoma (ccRCC) remains unclear.

    Authors: Yan Liu, Jian-Xing Wang, Zi-Yuan Nie, Yue Wen, Xin-Ju Jia, Li-Na Zhang, Hui-Jun Duan and Yong-Hong Shi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:439
    Content type: Research Published on:

  24. In the original publication of this article [1], there are mistakes in Fig. 4d. The corrected Fig. 4 should be:

    Authors: Sahyun Pak, Sejun Park, Yunlim Kim, Jung-Hyuck Park, Chan-Hee Park, Kyoung-June Lee, Choung-soo Kim and Hanjong Ahn
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:440
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:342

  25. In the original publication of this article,[1] the Funding section needs to be revised, and the corrected Funding section appears below.

    Authors: Morvarid Saeinasab, Ahmad Reza Bahrami, Jovanna González, Francesco P. Marchese, Dannys Martinez, Seyed Javad Mowla, Maryam M. Matin and Maite Huarte
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:441
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:172

  26. In the original publication of this article [1], the indicated stages (I-II III-IV) were missing in the clinical stage part at both Table 1 and Table 2.

    Authors: Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun and Dan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:442
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:329

  27. In the original publication of this article [1], the author would like to revise Figure 4.

    Authors: Meng-Xuan Zhu, Chuan-Yuan Wei, Peng-Fei Zhang, Dong-Mei Gao, Jie Chen, Yan Zhao, Shuang-Shuang Dong and Bin-Bin Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:443
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:409

  28. In the original publication of this article [1], there are mistakes in Fig. 3c and Fig. 3e.

    Authors: Yuyuan Yao, Kai Zhao, Zhou Yu, Haochuan Ren, Li Zhao, Zhiyu Li, Qinglong Guo and Na Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:444
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2017 36:103

  29. In the publication of our publication [1], we have noticed there is a wrong label in Fig. 1e, in which the position of “HCC” and “Adjacent” should be transposed.

    Authors: Wuhua Zhou, Li Gong, Qinchuan Wu, Chunyang Xing, Bajin Wei, Tianchi Chen, Yuan Zhou, Shengyong Yin, Bin Jiang, Haiyang Xie, Lin Zhou and Shusen Zheng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:445
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:215

  30. NOTCH1 gene mutations in mantle cell lymphoma (MCL) have been described in about 5–10% of cases and are associated with significantly shorter survival rates. The present study aimed to investigate the biological ...

    Authors: Elisabeth Silkenstedt, Fabian Arenas, Berta Colom-Sanmartí, Sílvia Xargay-Torrent, Morihiro Higashi, Ariadna Giró, Vanina Rodriguez, Patricia Fuentes, Walter E. Aulitzky, Heiko van der Kuip, Sílvia Beà, Maria L. Toribio, Elias Campo, Mònica López-Guerra and Dolors Colomer
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:446
    Content type: Research Published on:

  31. Molecular targeted therapy for advanced hepatocellular carcinoma (HCC) has changed markedly. Although sorafenib was used in clinical practice as the first molecular targeted agent in 2007, the SHARPE and Asian...

    Authors: Ziyu Liu, Yan Lin, Jinyan Zhang, Yumei Zhang, Yongqiang Li, Zhihui Liu, Qian Li, Ming Luo, Rong Liang and Jiazhou Ye
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:447
    Content type: Review Published on:

  32. A natural compound Jaspine B and its derivative possess potential anti-cancer activities; However, little is known about the underlying mechanism. Here, the role of a new autophagy inducer Jaspine B derivative...

    Authors: Haiyang Yu, Chun-Li Wu, Xiangyu Wang, Qianhong Ban, Chunhua Quan, Mengbo Liu, Hangqi Dong, Jinfeng Li, Gi-Young Kim, Yung Hyun Choi, Zhenya Wang and Cheng-Yun Jin
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:448
    Content type: Research Published on:

  33. Interleukin-8 (IL-8) plays a vital role in the invasion and metastasis of hepatocellular carcinoma (HCC), and is closely associated with poor prognosis of HCC patients. Integrin αvβ3, a member of the integrin ...

    Authors: Fengkai Sun, Jianping Wang, Qi Sun, Fanni Li, Hengjun Gao, Lin Xu, Jiao Zhang, Xiaoyan Sun, Yanan Tian, Qiujie Zhao, Huimin Shen, Kai Zhang and Jun Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:449
    Content type: Research Published on:

  34. Diffuse large B-cell lymphomas (DLBCLs) are aggressive lymphomas accounting for approximately a third of non-Hodgkin lymphomas. Prohibitin 1 (PHB1) and prohibitin 2 (PHB2) are scaffold proteins that promote mi...

    Authors: Hafidha Bentayeb, Marine Aitamer, Barbara Petit, Lydie Dubanet, Sabria Elderwish, Laurent Désaubry, Armand de Gramont, Eric Raymond, Agnès Olivrie, Julie Abraham, Marie-Odile Jauberteau and Danielle Troutaud
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:450
    Content type: Research Published on:

  35. In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article.

    Authors: Yuyuan Yao, Qinglong Guo, Yue Cao, Yangmin Qiu, Renxiang Tan, Zhou Yu, Yuxin Zhou and Na Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:451
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:282

  36. Increasing evidence shows that stimulated by retinoic acid 6 (STRA6) participates in regulating multiple cancers. However, the biological roles of STRA6 in gastric cancer (GC) remain unknown. This study aimed ...

    Authors: Linling Lin, Jian Xiao, Liang Shi, Wangwang Chen, Yugang Ge, Mingkun Jiang, Zengliang Li, Hao Fan, Li Yang and Zekuan Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:452
    Content type: Research Published on:

  37. The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug t...

    Authors: Liling Jiang, Yuening Sun, Jinxiang Wang, Qingyan He, Xinmei Chen, Xiaoying Lan, Jinghong Chen, Q. Ping Dou, Xianping Shi and Jinbao Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:453
    Content type: Research Published on:

  38. Limited effective intervention for advanced hepatocellular carcinoma (HCC) is available. This study aimed to investigate the potential clinical utility of apatinib, a highly selective inhibitor of the vascular...

    Authors: Junbin Liao, Huilin Jin, Shaoqiang Li, Lixia Xu, Zhenwei Peng, Guangyan Wei, Jianting Long, Yu Guo, Ming Kuang, Qi Zhou and Sui Peng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:454
    Content type: Research Published on:

  39. The regulatory non-coding RNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), emerge as pivotal markers during tumor progression. Abnormal sialylated glycoprotein often leads to the malignan...

    Authors: Bing Liu, Qianqian Liu, Shimeng Pan, Yiran Huang, Yu Qi, Shuangda Li, Yang Xiao and Li Jia
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:455
    Content type: Research Published on:

  40. Clinically, distant metastasis after primary treatment remains a key problem in nasopharyngeal carcinoma (NPC). Thus, identification of the underlying mechanisms and development of novel therapeutic strategies...

    Authors: You Zou, Rui Yang, Mao-Ling Huang, Yong-Gang Kong, Jian-Fei Sheng, Ze-Zhang Tao, Ling Gao and Shi-Ming Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:456
    Content type: Research Published on:

  41. MYO1C, an actin-based motor protein, is involved in the late stages of autophagosome maturation and fusion with the lysosome. The molecular mechanism by which MYO1C regulates autophagosome-lysosome fusion rema...

    Authors: Yanhao Zhang, Xiuxing Jiang, Qin Deng, Ziyi Gao, Xiangyu Tang, Ruoqiu Fu, Jinjiao Hu, Yunong Li, Lirong Li and Ning Gao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:457
    Content type: Research Published on:

  42. Hepatocellular carcinoma (HCC) still remains a dominating medical challenge in early diagnosis and clinical therapy. Centromere protein M (CENPM) has been proved to be over-expressed in HCC tissues, but carcin...

    Authors: Yusha Xiao, Rahmathullah Mohamed Najeeb, Dong Ma, Kang Yang, Qiu Zhong and Quanyan Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:458
    Content type: Research Published on:

  43. The biological behavior of epithelial ovarian cancer (EOC) is unique since EOC cells metastasize early to the peritoneum. Thereby, new anti-target agents designed to block trans-coelomic dissemination of EOC c...

    Authors: Michele Minopoli, Giovanni Botti, Vincenzo Gigantino, Concetta Ragone, Sabrina Sarno, Maria Letizia Motti, Giosuè Scognamiglio, Stefano Greggi, Cono Scaffa, Maria Serena Roca, Maria Patrizia Stoppelli, Gennaro Ciliberto, Nunzia Simona Losito and Maria Vincenza Carriero
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:459
    Content type: Research Published on:

  44. Breast cancer is the most prevalent cancer among women worldwide. WZ35, an analog of curcumin, has been demonstrated to remarkably improve the pharmacokinetic profiles in vivo compared with curcumin. WZ35 exhi...

    Authors: Lihua Wang, Canwei Wang, Zheying Tao, Liqian Zhao, Zheng Zhu, Wencan Wu, Ye He, Hong Chen, Bin Zheng, Xiangjie Huang, Yun Yu, Linjun Yang, Guang Liang, Ri Cui and Tongke Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:460
    Content type: Research Published on:

  45. Tumor cell repopulation after radiotherapy is a major cause for the tumor radioresistance and recurrence. This study aims to investigate the underlying mechanism of tumor repopulation after radiotherapy, with ...

    Authors: Yiwei Wang, Minghui Zhao, Sijia He, Yuntao Luo, Yucui Zhao, Jin Cheng, Yanping Gong, Jianzhu Xie, Yulan Wang, Binjie Hu, Ling Tian, Xinjian Liu, Chuanyuan Li and Qian Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:461
    Content type: Research Published on:

  46. We investigated the role of PD-L1 in the metabolic reprogramming of non-small cell lung cancer (NSCLC).

    Authors: Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A. Kim, Jin Chul Paeng, Chan-Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung and Yoon Kyung Jeon
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:462
    Content type: Research Published on:

  47. Overexpressed PES1 promotes carcinogenesis in various types of malignant tumors. However, the biological role and clinical significance of PES1 in pancreatic cancer are still unexplored.

    Authors: Xin Jin, Rui Fang, Ping Fan, Lipeng Zeng, Bin Zhang, Xiaoming Lu and Tao Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:463
    Content type: Research Published on:

  48. Prostate cancer (PCa) is a leading cause of cancer-related death in males worldwide. Exacerbated inflammation and angiogenesis have been largely demonstrated to contribute to PCa progression. Diverse naturally...

    Authors: Denisa Baci, Antonino Bruno, Caterina Cascini, Matteo Gallazzi, Lorenzo Mortara, Fausto Sessa, Giuseppe Pelosi, Adriana Albini and Douglas M. Noonan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:464
    Content type: Research Published on:

  49. Long non-coding RNAs (lncRNAs) are tumor-associated biological molecules and have been found to be implicated in the progression of colorectal cancer (CRC). This study aims to examine the effects of lncRNA RP1...

    Authors: Li Jiang, Xu-Hai Zhao, Yin-Ling Mao, Jun-Feng Wang, Hui-Jun Zheng and Qing-Shan You
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:465
    Content type: Research Published on:

  50. Circular RNAs (circRNAs) have recently been shown to play important roles in different tumors. However, their detailed roles and regulatory mechanisms in pancreatic ductal adenocarcinoma (PDAC) are not well un...

    Authors: Yan Chen, Zhonghu Li, Mengyun Zhang, Bo Wang, Jiaxin Ye, Yang Zhang, Di Tang, Dandan Ma, Weidong Jin, Xiaowu Li and Shuguang Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:466
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:137

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us